{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T12:23:44Z","timestamp":1765887824226},"reference-count":26,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["L'Enc\u00e9phale"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.encep.2015.12.027","type":"journal-article","created":{"date-parts":[[2016,9,14]],"date-time":"2016-09-14T21:00:18Z","timestamp":1473886818000},"page":"81-84","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Colite isch\u00e9mique sous qu\u00e9tiapine associ\u00e9e \u00e0 d\u2019autres mol\u00e9cules anticholinergiques\u00a0: \u00e0 propos d\u2019un cas"],"prefix":"10.1016","volume":"43","author":[{"given":"P.","family":"Cuny","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Houot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Ginisty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Horowicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Plassart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Mentec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Eftekhari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.encep.2015.12.027_bib0135","first-page":"52","article-title":"New antipsychotic agents","volume":"25","author":"Olie","year":"1999","journal-title":"Enc\u00e9phale"},{"issue":"6","key":"10.1016\/j.encep.2015.12.027_bib0140","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0013-7006(05)82427-3","article-title":"Analysis of differential clinical profiles of different antipsychotic molecules in the first psychotic episode: a retrospective study","volume":"31","author":"Spanarello","year":"2005","journal-title":"Enc\u00e9phale"},{"issue":"2","key":"10.1016\/j.encep.2015.12.027_bib0145","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.encep.2007.07.003","article-title":"Atypical antipsychotics in first-episode psychosis: a review","volume":"34","author":"Rotg\u00e9","year":"2008","journal-title":"Enc\u00e9phale"},{"issue":"5","key":"10.1016\/j.encep.2015.12.027_bib0150","first-page":"617","article-title":"Adverse effects of antipsychotic medications","volume":"81","author":"Muench","year":"2010","journal-title":"Am Fam Phys"},{"issue":"1\u20133","key":"10.1016\/j.encep.2015.12.027_bib0155","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.schres.2006.07.011","article-title":"A model of anticholinergic activity of atypical antipsychotic medications","volume":"88","author":"Chew","year":"2006","journal-title":"Schizophr Res"},{"issue":"30","key":"10.1016\/j.encep.2015.12.027_bib0160","doi-asserted-by":"crossref","first-page":"5214","DOI":"10.2174\/092986712803530476","article-title":"Anticholinergic effects of oral antipsychotic drugs of typicals versus atypicals over medium- and long-term: systematic review and meta-analysis","volume":"19","author":"Ozbilen","year":"2012","journal-title":"Curr Med Chem"},{"issue":"10","key":"10.1016\/j.encep.2015.12.027_bib0165","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1002\/pds.1801","article-title":"Antipsychotics-induced ischaemic colitis and gastrointestinal necrosis: a review of the French pharmacovigilance database","volume":"18","author":"Peyri\u00e8re","year":"2009","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"5","key":"10.1016\/j.encep.2015.12.027_bib0170","first-page":"397","article-title":"Pseudo-obstruction of the colon","volume":"65","author":"Spira","year":"1976","journal-title":"Am J Gastroenterol"},{"issue":"12","key":"10.1016\/j.encep.2015.12.027_bib0175","first-page":"577","article-title":"Ent\u00e9rocolite aigu\u00eb n\u00e9crosante au cours d\u2019un traitement prolong\u00e9 par neuroleptiques","volume":"24","author":"Ausseur","year":"1995","journal-title":"Presse Med"},{"issue":"2","key":"10.1016\/j.encep.2015.12.027_bib0180","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1055\/s-2005-870890","article-title":"Acute intestinal pseudo-obstruction (Ogilvie's syndrome)","volume":"18","author":"Maloney","year":"2005","journal-title":"Clin Colon Rectal Surg"},{"issue":"3","key":"10.1016\/j.encep.2015.12.027_bib0185","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/BF02555027","article-title":"Acute pseudo-obstruction of the colon (Ogilvie's syndrome). An analysis of 400\u00a0cases","volume":"29","author":"Vanek","year":"1986","journal-title":"Dis Colon Rectum"},{"issue":"3","key":"10.1016\/j.encep.2015.12.027_bib0190","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1056\/NEJM199907153410301","article-title":"Neostigmine for the treatment of acute colonic pseudo-obstruction","volume":"341","author":"Ponec","year":"1999","journal-title":"New Engl J Med"},{"issue":"5","key":"10.1016\/j.encep.2015.12.027_bib0195","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1152\/ajpgi.2001.281.5.G1228","article-title":"Cholinergic stimulation enhances colonic motor activity, transit, and sensation in humans","volume":"281","author":"Law","year":"2001","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"6","key":"10.1016\/j.encep.2015.12.027_bib0200","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1111\/j.1572-0241.2004.30192.x","article-title":"Colonic toxicity of administered drugs and chemicals","volume":"99","author":"Cappell","year":"2004","journal-title":"Am J Gastroenterol"},{"issue":"9","key":"10.1016\/j.encep.2015.12.027_bib0205","first-page":"435","article-title":"The acute pseudobstruction of the colon, or Ogilvie's syndrome: a rare cause of acute abdomen, high mortality and associated pathologies in an internal medicine department","volume":"23","author":"Montero Leal","year":"2006","journal-title":"An Med Int"},{"issue":"3","key":"10.1016\/j.encep.2015.12.027_bib0210","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1093\/schbul\/sbq137","article-title":"Risk factors for ileus in patients with schizophrenia","volume":"38","author":"Nielsen","year":"2012","journal-title":"Schizophr Bull"},{"issue":"4","key":"10.1016\/j.encep.2015.12.027_bib0215","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/YIC.0b013e32805b71a3","article-title":"Dose-dependent constipation with higher doses of quetiapine: a case series","volume":"22","author":"Raedler","year":"2007","journal-title":"Int Clin Psychopharmacol"},{"issue":"11","key":"10.1016\/j.encep.2015.12.027_bib0220","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.kjms.2011.06.014","article-title":"Rapid initiation of quetiapine well tolerated as compared with the conventional initiation regimen in patients with schizophrenia or schizoaffective disorders","volume":"27","author":"Hsiao","year":"2011","journal-title":"Kaohsiung J Med Sci"},{"key":"10.1016\/j.encep.2015.12.027_bib0225","series-title":"8e Congr\u00e8s de physiologie, de pharmacologie et de th\u00e9rapeutique","article-title":"Quetiapine-induced ischemic colitis: review of the French Phamacovigilance database","author":"Pinzani","year":"2013"},{"issue":"1","key":"10.1016\/j.encep.2015.12.027_bib0230","first-page":"61","article-title":"Clinical study of a new agent correcting the syndrome of neuroleptic impregnation in acute psychotic states","volume":"1","author":"Vauterin","year":"1975","journal-title":"Enc\u00e9phale"},{"issue":"3","key":"10.1016\/j.encep.2015.12.027_bib0235","doi-asserted-by":"crossref","first-page":"198","DOI":"10.2165\/00003495-197815030-00002","article-title":"Loxapine: a review of its pharmacological properties and therapeutic efficacy as an antipsychotic agent","volume":"15","author":"Heel","year":"1978","journal-title":"Drugs"},{"issue":"4","key":"10.1016\/j.encep.2015.12.027_bib0240","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001943.pub2","article-title":"Loxapine for schizophrenia","volume":"17","author":"Chakrabarti","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"10.1016\/j.encep.2015.12.027_bib0245","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1517\/13543784.5.8.939","article-title":"Seroquel (quetiapine): preclinical and clinical findings of a new atypical antipsychotic","volume":"5","author":"Casey","year":"1996","journal-title":"Exp Opin Invest Drugs"},{"issue":"13","key":"10.1016\/j.encep.2015.12.027_bib0250","first-page":"5","article-title":"Quetiapine: preclinical studies, pharmacokinetics, drug interactions, and dosing","volume":"63","author":"Nemeroff","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.encep.2015.12.027_bib0255","series-title":"R\u00e9sum\u00e9 des caract\u00e9ristiques du produit (RCP) Xeroquel\u00ae. [Online]","author":"Agence nationale de s\u00e9curit\u00e9 du m\u00e9dicament et des produits de sant\u00e9","year":"2014"},{"key":"10.1016\/j.encep.2015.12.027_bib0130","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3389\/fpsyt.2013.00102","article-title":"Active metabolites as antidepressant drugs: the role of norquetiapine in the mechanism of action of quetiapine in the treatment of mood disorders","volume":"4","author":"L\u00f3pez-Mu\u00f1oz","year":"2013","journal-title":"Front Psychiatry"}],"container-title":["L'Enc\u00e9phale"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0013700616301774?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0013700616301774?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,13]],"date-time":"2019-09-13T13:56:58Z","timestamp":1568383018000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0013700616301774"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S0013700616301774"],"URL":"https:\/\/doi.org\/10.1016\/j.encep.2015.12.027","relation":{},"ISSN":["0013-7006"],"issn-type":[{"value":"0013-7006","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Colite isch\u00e9mique sous qu\u00e9tiapine associ\u00e9e \u00e0 d\u2019autres mol\u00e9cules anticholinergiques\u00a0: \u00e0 propos d\u2019un cas","name":"articletitle","label":"Article Title"},{"value":"L'Enc\u00e9phale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.encep.2015.12.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 L'Enc\u00e9phale, Paris.","name":"copyright","label":"Copyright"}]}}